support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulleted grid_view

11/19/2021

CHEPLAPHARM continues strong Growth
Archive Press releases
Read more chevron_right

06/22/2020

CHEPLAPHARM acquires two product portfolios

Greifswald, 06/22/2020


Investors Domain Archive
Read more chevron_right

05/15/2020

CHEPLAPHARM wins again

Greifswald, 05/15/2020 – The family-owned pharmaceutical company CHEPLAPHARM Arzneimittel GmbH got honoured with the highly coveted 'Axia Best Managed Companies Award' for the second time in a row.…


Archive
Read more chevron_right

03/30/2020

Corona Virus (COVID-19) Impact on CHEPLAPHARM activities

Due to the COVID-19 situation, CHEPLAPHARM Arzneimittel GmbH is closely monitoring the potential impact on the various Supply Chains and is committed to keep a transparent approach to all…


Archive
Read more chevron_right

01/29/2020

CHEPLAPHARM’s successful institutional bond debut: 500 million euros of senior secured notes at 3.500% placed with institutional investors

CHEPLAPHARM Arzneimittel GmbH, a repeat issuer in the long-term loan market with 980 million euros of institutional term loan (“TLB”) outstanding, following its last capital market transaction in May…


Investor Relations Archive Press releases
Read more chevron_right

01/28/2020

CHEPLAPHARM announces pricing of Senior Secured Notes

Cheplapharm has priced €500 million aggregate principal amount of its 3.500% senior secured notes due 2027 (the “Notes”), at an offering price of 100.0%.


Archive Investor Relations
Read more chevron_right

01/23/2020

CHEPLAPHARM announces offering of Senior Secured Notes

Cheplapharm Arzneimittel GmbH has launched an offering of €400 million aggregate principal amount of senior secured notes due 2027.


Archive
Read more chevron_right

07/29/2019

Minister-President Schwesig visits CHEPLAPHARM

Schwerin/Greifswald (DE), 07/26/2019 – As part of her summer tour through Mecklenburg-Western Pomerania, Minister-President Manuela Schwesig stops by at the CHEPLAPHARM company headquarters in…


Archive
Read more chevron_right

06/19/2019

CHEPLAPHARM's third capital market transaction five times oversubscribed

London/Greifswald, June 13, 2019 – CHEPLAPHARM Arzneimittel GmbH very successfully closed its third capital markets transaction within just one year. Offering additional 150 million euros Term Loan B…


Archive
Read more chevron_right

Back

Back to top expand_less